PGIM Fixed Income has previously examined how various emerging market economies might weather the pandemic through four lenses: virus exposure, pre-existing macro vulnerabilities, exposure to global economic deterioration, and respective policy responses. As vaccine rollouts facilitate an acceleration in economic activity, we turn our attention to which emerging markets may be best positioned to benefit from the recovery in the developed markets and China. This analysis involves determining an EM country’s export orientation—in terms of GDP share and types of goods exported—towards these engines of growth. READ MORE
Similar Posts:
- Reshaping Supply Chains Away From China (The Asset)
- The World in 2050 (PWC)
- What Explains Emerging Markets’ Relatively Low COVID-19 Fatality Rate? (LGIM)
- Experts: Tread Carefully With Emerging Market Investments (FE Trustnet)
- Uncommon Yields: How China is a Rare Bright Spot in a World Deprived of Yield (KraneShares)
- With China on ‘Extended’ Path to Reopening, Emerging Market Equities Will Outperform Peers in Developed Economies, Record Double-digit Growth, Allspring Analyst Says (SCMP)
- Shift Your Emerging Market Consumer Exposure from MNCs to Local Stocks (FE Trustnet)
- Sustained Growth Slowdown in China Would Spill Over to Asia-Pacific Region and Beyond (Moody’s Talk)
- Is Your Emerging Market Strategy Overexposed to These 3 Factors? (KraneShares)
- Global Emerging Markets: Country Allocation Review 2021 (Federated Hermes)
- China beyond Evergrande: Contagion or containment? (PineBridge Investments)
- China: A Visit to the Epicenter (KKR)
- Chart: Stock Market Capitalization as a Percent of GDP (Guggenheim Investments)
- What’s Really Driving China’s Currency Stability (KraneShares)
- Pick Stocks, Not Countries, in Emerging Markets (FE Trustnet)
